Year archive

SynAct Pharma — 2025 filings

All 61 regulatory filings released by SynAct Pharma (SYNACT) in 2025, sourced directly from the official regulator.

61 Filings

2025 Period

2025 filings (61)

Filing	Released	Lang
Valberedning utsedd inför årsstämman 2026 i SynAct Pharma AB Regulatory Filings	2025-12-11	Swedish
Nomination committee appointed ahead of AGM 2026 in SynAct Pharma AB Regulatory Filings	2025-12-11	English
Report from the Extraordinary General Meeting of SynAct Pharma AB AGM Information	2025-11-27	English
Kommuniké från extra bolagsstämma i SynAct Pharma AB AGM Information	2025-11-27	Swedish
Interim / Quarterly Report 2025 Interim / Quarterly Report 9M 2025	2025-10-30	Swedish
Interim / Quarterly Report 2025 Interim / Quarterly Report 9M 2025	2025-10-30	English
KALLELSE TILL EXTRA BOLAGSSTÄMMA I SYNACT PHARMA AB (PUBL) Proxy Solicitation & Information Statement	2025-10-29	Swedish
NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF SYNACT PHARMA AB Proxy Solicitation & Information Statement	2025-10-29	English
Förslag till beslut om bemyndigande för styrelsen att besluta om förvärv och överlåtelse av egna aktier Share Issue/Capital Change	2025-09-29	Swedish
Proposal for a resolution on authorization for the Board of Directors to resolve on acquisition and transfer of own shares Transaction in Own Shares	2025-09-29	English
SynAct Pharma’s CFO Björn Westberg leaves for new leading position Board/Management Information	2025-09-16	English
SynAct Pharmas CFO Björn Westberg slutar för ny ledande befattning Board/Management Information	2025-09-16	Swedish
Förändring av antalet aktier och röster i SynAct Pharma AB Share Issue/Capital Change	2025-08-29	Swedish
Change in number of shares and votes in SynAct Pharma AB Share Issue/Capital Change	2025-08-29	English
Interim / Quarterly Report 2025 Interim / Quarterly Report H1 2025	2025-08-20	Swedish
Interim / Quarterly Report 2025 Interim / Quarterly Report Q2 2025	2025-08-20	English
SynAct tillförs 17,7 MSEK efter en andra konvertering av teckningsoptioner Share Issue/Capital Change	2025-08-15	Swedish
SynAct to receive SEK 17.7 million after second conversion of warrants Share Issue/Capital Change	2025-08-15	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-08-05	Swedish
Förändring av antalet aktier och röster i SynAct Pharma AB Share Issue/Capital Change	2025-07-31	Swedish
Change in number of shares and votes in SynAct Pharma AB Share Issue/Capital Change	2025-07-31	English
Correction: SynAct to receive SEK 17.7 million after conversion of warrants Share Issue/Capital Change	2025-07-15	English
Rättelse: SynAct tillförs 17,7 MSEK efter konvertering av teckningsoptioner Share Issue/Capital Change	2025-07-15	Swedish
SynAct tillförs 17,7 MSEK efter konvertering av teckningsoptioner Capital/Financing Update	2025-07-15	Swedish
SynAct to receive SEK 17.7 million after conversion of warrants Share Issue/Capital Change	2025-07-15	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-07-11	Swedish
Förändring av antalet aktier och röster i SynAct Pharma AB Declaration of Voting Results & Voting Rights Announcements	2025-06-30	Swedish
Change in number of shares and votes in SynAct Pharma AB Declaration of Voting Results & Voting Rights Announcements	2025-06-30	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-06-13	Swedish
SynAct Pharma AB genomför en riktad nyemission om 37 MSEK och förlänger sin finansiella runway till slutet av 2026 Capital/Financing Update	2025-06-04	Swedish
SynAct Pharma AB carries out a directed share issue of SEK 37 million and extends its financial runway to end of 2026 Capital/Financing Update	2025-06-04	English
SynAct Pharma upptar en kreditfacilitet om 30 MSEK som förlänger bolagets finansiella runway till mitten av 2026 och stärker samtidigt partnerskapsmöjligheter Capital/Financing Update	2025-06-03	Swedish
SynAct Pharma takes out a credit facility of SEK 30 million that extends the company’s financial runway to mid-2026, which strongly strengthens partnership opportunities. Capital/Financing Update	2025-06-03	English
Kommuniké från årsstämma 2025 i SynAct Pharma AB AGM Information	2025-05-27	Swedish
Bulletin from the annual general meeting 2025 in SynAct Pharma AB AGM Information	2025-05-27	English
Interim / Quarterly Report 2025 Interim / Quarterly Report Q1 2025	2025-05-27	Swedish
Interim / Quarterly Report 2025 Interim / Quarterly Report Q1 2025	2025-05-27	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-05-22	Swedish
Major Shareholding Notification 2025 Major Shareholding Notification	2025-05-20	Swedish
Major Shareholding Notification 2025 Major Shareholding Notification	2025-05-15	Swedish
Notice of annual general meeting in SynAct Pharma AB AGM Information	2025-04-24	English
Kallelse till årsstämma i SynAct Pharma AB AGM Information	2025-04-24	Swedish
Annual Report (ESEF) 2024 Annual Report (ESEF) FY 2024	2025-04-10	Swedish
Major Shareholding Notification 2025 Major Shareholding Notification	2025-03-10	Swedish
Director's Dealing 2025 Director's Dealing	2025-03-05	Swedish
Major Shareholding Notification 2025 Major Shareholding Notification	2025-03-04	Swedish
Director's Dealing 2025 Director's Dealing	2025-02-26	Swedish
Major Shareholding Notification 2025 Major Shareholding Notification	2025-02-24	Swedish
Major Shareholding Notification 2025 Major Shareholding Notification	2025-02-21	Swedish
SynAct’s Nomination Committee proposes Jeppe Ragnar Andersen to the Board Board/Management Information	2025-02-20	English
SynActs valberedning föreslår Jeppe Ragnar Andersen till ny styrelseledamot Board/Management Information	2025-02-20	Swedish
Interim / Quarterly Report 2024 Interim / Quarterly Report Q4 2024	2025-02-18	Swedish
Interim / Quarterly Report 2024 Interim / Quarterly Report Q4 2024	2025-02-18	English
Change in number of shares and votes in SynAct Pharma AB Declaration of Voting Results & Voting Rights Announcements	2025-01-31	English
Förändring av antalet aktier och röster i SynAct Pharma AB Share Issue/Capital Change	2025-01-31	Swedish
SynAct Pharma AB resolves on a directed share issue to guarantors Share Issue/Capital Change	2025-01-09	English
SynAct Pharma AB beslutar om riktad nyemission av aktier till garantigivare Share Issue/Capital Change	2025-01-09	Swedish
SynAct Pharma AB resolves on a directed share issue to guarantors Capital/Financing Update	2025-01-09	English
SynAct Pharma AB beslutar om riktad nyemission av aktier till garantigivare Capital/Financing Update	2025-01-09	Swedish
SynAct Pharma AB offentliggör utfall i företrädesrättsemissionen Share Issue/Capital Change	2025-01-09	Swedish
SynAct Pharma AB announces outcome of the rights issue Share Issue/Capital Change	2025-01-09	English